Sunshine Biopharma Inc (SBFM)
0.89
-0.03
(-3.68%)
USD |
NASDAQ |
May 10, 16:00
0.88
-0.01
(-1.12%)
After-Hours: 20:00
Sunshine Biopharma Cash and Short Term Investments (Quarterly): 16.29M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 16.29M |
| September 30, 2023 | 18.85M |
| June 30, 2023 | 19.73M |
| March 31, 2023 | 19.29M |
| December 31, 2022 | 21.83M |
| September 30, 2022 | 40.56M |
| June 30, 2022 | 41.73M |
| March 31, 2022 | 13.18M |
| December 31, 2021 | 2.045M |
| September 30, 2021 | 2.387M |
| June 30, 2021 | 1.735M |
| March 31, 2021 | 1.797M |
| December 31, 2020 | 0.9899M |
| September 30, 2020 | 0.4887M |
| June 30, 2020 | 0.0856M |
| March 31, 2020 | 0.0108M |
| December 31, 2019 | 0.0405M |
| September 30, 2019 | 0.082M |
| June 30, 2019 | 0.0373M |
| March 31, 2019 | 0.0951M |
| December 31, 2018 | 0.1105M |
| September 30, 2018 | 0.0464M |
| June 30, 2018 | 0.0364M |
| March 31, 2018 | 0.1048M |
| December 31, 2017 | 0.1075M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.1881M |
| June 30, 2017 | 0.1288M |
| March 31, 2017 | 0.0171M |
| December 31, 2016 | 0.0575M |
| September 30, 2016 | 0.0218M |
| June 30, 2016 | 0.0739M |
| March 31, 2016 | 0.1233M |
| December 31, 2015 | 0.0508M |
| September 30, 2015 | 0.1252M |
| June 30, 2015 | 0.1572M |
| March 31, 2015 | 0.1487M |
| December 31, 2014 | 0.1434M |
| September 30, 2014 | 0.1739M |
| June 30, 2014 | 0.0384M |
| March 31, 2014 | 0.0705M |
| December 31, 2013 | 0.0312M |
| September 30, 2013 | 0.071M |
| June 30, 2013 | 0.1566M |
| March 31, 2013 | 0.2559M |
| December 31, 2012 | 0.1326M |
| September 30, 2012 | 0.2554M |
| June 30, 2012 | 0.0632M |
| March 31, 2012 | 0.0384M |
| December 31, 2011 | 0.0607M |
| September 30, 2011 | 0.1785M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.0108M
Minimum
Mar 2020
41.73M
Maximum
Jun 2022
10.59M
Average
2.045M
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Lexaria Bioscience Corp | 4.793M |
| Acasti Pharma Inc | 25.11M |
| Aurinia Pharmaceuticals Inc | 350.49M |
| Edesa Biotech Inc | 4.268M |
| Xenon Pharmaceuticals Inc | 638.08M |